#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA872828	F	Compound was tested for the inhibition of non- small cell lung cancer	Homo sapiens	1		cell-based format	Scientific Literature
2.	ALA918680	F	Antitumor activity against human NCI non-small cell lung cancer cell line panel	Homo sapiens	3		cell-based format	Scientific Literature
3.	ALA5249571	F	Cytotoxicity against human Non-small cell lung cancer cell line assessed as growth percent at 10 uM incubated for 48 hrs	Homo sapiens	1		cell-based format	Scientific Literature
4.	ALA4420447	A	Growth inhibition of human NSCLC expressing wild type KRAS	Homo sapiens	16		cell-based format	Patent Bioactivity Data
5.	ALA4420448	F	Growth inhibition of human NSCLC expressing mutant KRAS	Homo sapiens	16		cell-based format	Patent Bioactivity Data
6.	ALA4420449	F	Growth inhibition of human NSCLC expressing mutant KRAS assessed as inhibition of 2D cell growth	Homo sapiens	15		cell-based format	Patent Bioactivity Data
7.	ALA4420450	F	Growth inhibition of human NSCLC expressing mutant KRAS assessed as inhibition of 3D cell growth	Homo sapiens	6		cell-based format	Patent Bioactivity Data
8.	ALA4428499	F	Antitumor activity against human NSCLC xenografted in Balb/c-nu mouse assessed as inhibition of tumor growth at 12.5 mg/kg, ip dosed every day for 21 consecutive days and measured every 3 days	Homo sapiens	1		organism-based format	Scientific Literature
9.	ALA4428500	F	Antitumor activity against human NSCLC xenografted in Balb/c-nu mouse assessed as inhibition of tumor growth at 50 mg/kg, ip dosed every day for 21 consecutive days and measured every 3 days	Homo sapiens	1		organism-based format	Scientific Literature
10.	ALA4428501	F	Antitumor activity against human NSCLC xenografted in Balb/c-nu mouse assessed as induction of delay in tumor volume increase at 12.5 mg/kg, ip dosed every day for 21 consecutive days and measured every 3 days	Homo sapiens	1		organism-based format	Scientific Literature
11.	ALA4428502	F	Antitumor activity against human NSCLC xenografted in Balb/c-nu mouse assessed as induction of delay in tumor volume increase at 50 mg/kg, ip dosed every day for 21 consecutive days and measured every 3 days	Homo sapiens	1		organism-based format	Scientific Literature
12.	ALA5096393	F	Cytotoxicity against human non-small cell lung cancer cell line assessed as reduction in cell viability by MTT assay relative to control	Homo sapiens	2		cell-based format	Scientific Literature